Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients

CompletedOBSERVATIONAL
Enrollment

411

Participants

Timeline

Start Date

July 2, 2020

Primary Completion Date

December 18, 2020

Study Completion Date

December 18, 2020

Conditions
Parkinson DiseaseCOVID
Interventions
OTHER

Questionnaire and interview

The questionnaires are Parkinson Disease Questionnaire-8 Items (PDQ-8) Visual Analog Scale (VAS) is visual analog scale visual numeric from 0 to 100, Neuropsychiatric Inventory-Questionnaire-Reduced (NPI-R) and Clinical Global Impression-Impairment (CGI-I).

Trial Locations (8)

13385

Centre Hospitalier Universitaire de Marseille, Marseille

25030

Centre Hospitalier Régionale Universitaire de Besançon, Besançon

30029

Centre Hospitalier Universitaire de Nîmes - Caremeau, Nîmes

31000

CHU Toulouse, Toulouse

51100

Centre Hospitalier Universitaire de Reims, Reims

59037

Centre Hospitalier Universitaire Lille, Lille

75013

Centre Hospitalier Universitaire de la Pitié-Salpêtrière, Paris

76031

Centre Hospitalier Universitaire de Rouen, Rouen

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT04466839 - Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients | Biotech Hunter | Biotech Hunter